Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

C8261

Sodium chenodeoxycholate

≥97%

Synonym(s):

3α,7α-Dihydroxy-5β-cholanic acid, 5β-Cholanic acid-3α,7α-diol, Chenodeoxycholic acid sodium salt, Chenodesoxycholic acid, Chenodiol

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
500 mg
Please contact Customer Service for Availability
$83.10
1 g
Please contact Customer Service for Availability
$141.00

About This Item

Empirical Formula (Hill Notation):
C24H39NaO4
CAS Number:
2646-38-0
Molecular Weight:
414.55
NACRES:
NA.25
PubChem Substance ID:
24893037
UNSPSC Code:
12161900
MDL number:
MFCD00065452

$83.10

Please contact Customer Service for Availability
​
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

anionic

Quality Level

200

assay

≥97%

form

powder

mol wt

414.55 g/mol

technique(s)

protein purification: suitable

SMILES string

[Na].[H][C@@]12C[C@H](O)CC[C@]1(C)[C@@]3([H])CC[C@]4(C)[C@]([H])(CC[C@@]4([H])[C@]3([H])[C@H](O)C2)[C@H](C)CCC(O)=O

InChI

1S/C24H40O4.Na.H/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26;;/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28);;/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-;;/m1../s1

InChI key

WANBNZVOEKGHSS-VQNKLXGESA-N

General description

Sodium chenodeoxycholate is a bile salt, which has been shown to accelerate colonic transit and improve bowel function. [1]

Application

Sodium chenodeoxycholate has been used in a study to assess DNA repair response in the bacterium Escherichia coli. [2] It has also been used in a study to investigate the physical and chemical factors influencing germination of Clostridium difficile spores. [3]

Biochem/physiol Actions

Bile Salt

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
30970C644527029
Sodium chenodeoxycholate ≥97%

Sigma-Aldrich

C8261

Sodium chenodeoxycholate

Sodium deoxycholate BioXtra, ≥98.0% (dry matter, NT)

Sigma-Aldrich

30970

Sodium deoxycholate

Sodium cholate hydrate BioXtra, ≥99%

Sigma-Aldrich

C6445

Sodium cholate hydrate

Sodium cholate hydrate ≥97.0% (dried material, NT)

Sigma-Aldrich

27029

Sodium cholate hydrate

technique(s)

protein purification: suitable

technique(s)

DNA purification: suitable, RNA purification: suitable, electrophoresis: suitable

technique(s)

-

technique(s)

-

assay

≥97%

assay

≥98.0% (dry matter, NT)

assay

≥99%

assay

≥97.0% (dried material, NT)

form

powder

form

powder

form

powder

form

powder

description

anionic

description

anionic

description

anionic

description

anionic

mol wt

414.55 g/mol

mol wt

micellar avg mol wt 1200-5000

mol wt

micellar avg mol wt 900-1300

mol wt

micellar avg mol wt 900-1300

Quality Level

200

Quality Level

300

Quality Level

200

Quality Level

200

pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Repr. 2

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000517528
0000517528
0000457370
0000457369
0000457370

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Probiotics and Human Health

Probiotics exhibit an inhibitory effect on pathogens, help prevent chronic intestinal inflammatory diseases or atopic syndromes, and support the immune system.

L J Wheeldon et al.
Journal of applied microbiology, 105(6), 2223-2230 (2009-01-06)
To investigate the influence of chemical and physical factors on the rate and extent of germination of Clostridium difficile spores. Germination of C. difficile spores following exposure to chemical and physical germinants was measured by loss of either heat or
V Vanhoorne et al.
Orphanet journal of rare diseases, 14(1), 186-186 (2019-08-03)
Pharmaceutical compounding of orphan active ingredients can offer cost-effective treatment to patients when no other drug product is available for a rare disease or during periods of drug product shortages. Additionally, it allows customized therapy for patients with rare diseases.
Tina Kauss et al.
Journal of pharmaceutical sciences, 108(8), 2805-2813 (2019-03-18)
Current pediatric antibiotic therapies often use oral and parenteral routes of administration. Neither are suitable for treating very sick neonates who cannot take oral medication and may be several hours away from hospital in developing countries. Here, we report on
View All Related Papers

Global Trade Item Number

SKUGTIN
C8261-1G04061833521984
C8261-500MG04061833619117

Questions

Reviews

No rating value

Active Filters